122 related articles for article (PubMed ID: 36200501)
1. [Participation indicators of colorectal screenings in Hungary between 2008-2021].
Kívés Z; Bódis J; Hunyady B; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Vajda R; Boncz I
Magy Onkol; 2022 Oct; 66(3):209-217. PubMed ID: 36200501
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the population-based pilot colorectal cancer screening, Csongrád county, Hungary, 2015.
Rutka M; Bor R; Molnár T; Farkas K; Pigniczki D; Fábián A; Györffy M; Bálint A; Milassin Á; Szücs M; Tiszlavicz L; Nagy F; Szepes Z
Turk J Med Sci; 2020 Jun; 50(4):756-763. PubMed ID: 32151116
[TBL] [Abstract][Full Text] [Related]
3. [Quality and performance indicators of colorectal cancer screening pilot program in Csongrád County, Hungary].
Kivés Z; Kovács A; Budai A; Döbrõssy L; Vajda R; Endrei D; Boncz I
Magy Onkol; 2019 Jun; 63(2):125-132. PubMed ID: 31225536
[TBL] [Abstract][Full Text] [Related]
4. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of the population-based pilot colorectal screening program. Hungary, Csongrád county, 2015].
Rutka M; Molnár T; Bor R; Farkas K; Fábián A; Győrfi M; Bálint A; Milassin Á; Szűcs M; Tiszlavicz L; Nagy F; Szepes Z
Orv Hetil; 2017 Oct; 158(42):1658-1667. PubMed ID: 29037058
[TBL] [Abstract][Full Text] [Related]
6. [Participation indicators of organized cervical cancer screening in Hungary].
Vajda R; Bódis J; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Kívés Z; Boncz I
Magy Onkol; 2022 Oct; 66(3):186-193. PubMed ID: 36200498
[TBL] [Abstract][Full Text] [Related]
7. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study.
Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M
Elife; 2023 Jan; 12():. PubMed ID: 36695411
[TBL] [Abstract][Full Text] [Related]
8. [Participation indicators of organized mammography screening in Hungary between 2012-2021].
Laczó A; Bódis J; Bogner P; Molnár K; Vajda R; Pónusz-Kovács D; Elmer D; Kajos FL; Csákvári T; Kívés Z; Boncz I
Magy Onkol; 2022 Oct; 66(3):195-200. PubMed ID: 36200499
[TBL] [Abstract][Full Text] [Related]
9. [Participation rates in the third round (2006-2007) of the breast cancer screening program in Hungary].
Boncz I; Döbrõssy L; Péntek Z; Kovács A; Budai A; Vajda R; Sebestyén A
Magy Onkol; 2013 Sep; 57(3):140-6. PubMed ID: 24107819
[TBL] [Abstract][Full Text] [Related]
10. Pandemic-resilient target setting in colorectal cancer screening for vulnerable older population.
Shibata T; Shinjo D; Takahashi J; Fushimi K
Cancer Med; 2023 Jan; 12(1):619-630. PubMed ID: 35666024
[TBL] [Abstract][Full Text] [Related]
11. [Estimated impact of the current colorectal screening program in France].
Barré S; Leleu H; Vimont A; Kaufmanis A; Gendre I; Taleb S; De Bels F
Rev Epidemiol Sante Publique; 2020 Jun; 68(3):171-177. PubMed ID: 32417153
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 related decline in cancer screenings most pronounced for elderly patients and women in Germany: a claims data analysis.
Muschol J; Strauss C; Gissel C
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5345-5367. PubMed ID: 36436091
[TBL] [Abstract][Full Text] [Related]
13. Disparities in the Participation Rate of Colorectal Cancer Screening by Fecal Occult Blood Test among People with Disabilities: A National Database Study in South Korea.
Shin DW; Chang D; Jung JH; Han K; Kim SY; Choi KS; Lee WC; Park JH; Park JH
Cancer Res Treat; 2020 Jan; 52(1):60-73. PubMed ID: 31096735
[TBL] [Abstract][Full Text] [Related]
14. [Factors influencing the participation in colorectal screening].
Döbrőssy L; Kovács A; Cornides A; Budai A
Orv Hetil; 2014 Jul; 155(27):1051-6. PubMed ID: 24974839
[TBL] [Abstract][Full Text] [Related]
15. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
Machii R; Takahashi H
Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer population screening programs worldwide in 2016: An update.
Navarro M; Nicolas A; Ferrandez A; Lanas A
World J Gastroenterol; 2017 May; 23(20):3632-3642. PubMed ID: 28611516
[TBL] [Abstract][Full Text] [Related]
17. Impact of screening colonoscopy on outcomes in colorectal cancer.
Matsuda T; Ono A; Kakugawa Y; Matsumoto M; Saito Y
Jpn J Clin Oncol; 2015 Oct; 45(10):900-5. PubMed ID: 26254299
[TBL] [Abstract][Full Text] [Related]
18. The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities.
Boncz I; Sebestyén A; Pintér I; Battyány I; Ember I
J Med Screen; 2008; 15(1):14-7. PubMed ID: 18416949
[TBL] [Abstract][Full Text] [Related]
19. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
Patel VB; Nahar R; Murray B; Salner AL
Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
[TBL] [Abstract][Full Text] [Related]
20. Participation rates for organized colorectal cancer screening programmes: an international comparison.
Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
